These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 36860172)
21. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. Brady S; Squier W; Hilton-Jones D J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1240-6. PubMed ID: 23864699 [TBL] [Abstract][Full Text] [Related]
22. Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers. Buzkova J; Nikkanen J; Ahola S; Hakonen AH; Sevastianova K; Hovinen T; Yki-Järvinen H; Pietiläinen KH; Lönnqvist T; Velagapudi V; Carroll CJ; Suomalainen A EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30373890 [TBL] [Abstract][Full Text] [Related]
23. Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis. Lucchini M; De Arcangelis V; Santoro M; Morosetti R; Broccolini A; Mirabella M Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446317 [TBL] [Abstract][Full Text] [Related]
24. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients. Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370 [TBL] [Abstract][Full Text] [Related]
25. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790 [TBL] [Abstract][Full Text] [Related]
26. Inclusion Body Myositis. Goyal NA Continuum (Minneap Minn); 2022 Dec; 28(6):1663-1677. PubMed ID: 36537974 [TBL] [Abstract][Full Text] [Related]
27. Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings. Pinto MV; Laughlin RS; Klein CJ; Mandrekar J; Naddaf E Rheumatology (Oxford); 2022 May; 61(6):2504-2511. PubMed ID: 34617994 [TBL] [Abstract][Full Text] [Related]
28. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles]. Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175 [TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of inclusion body myositis. Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316 [TBL] [Abstract][Full Text] [Related]
38. Multiple mitochondrial DNA deletions in hereditary inclusion body myopathy. Jansson M; Darin N; Kyllerman M; Martinsson T; Wahlström J; Oldfors A Acta Neuropathol; 2000 Jul; 100(1):23-8. PubMed ID: 10912916 [TBL] [Abstract][Full Text] [Related]
39. Inclusion body myositis: a case of bilateral extremity weakness. Lam L; Scheper S; Zagorski N; Chung M; Noguchi H; Liow KK Hawaii J Med Public Health; 2013 Dec; 72(12):417-20. PubMed ID: 24377075 [TBL] [Abstract][Full Text] [Related]
40. Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras. De Paepe B Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30621041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]